Abstract
Primary vesicoureteric reflux was felt to result from a congenitally short mucosal tunnel length with oblique intravescical insertion but more recent data suggest that primary vesicoureteric reflux is often associated with functional urodynamic abnormalities. There is now sound evidence that primary vesicoureteric reflux has a familial basis; most findings suggest a dominant inheritance with incomplete penetrance. Primary vesicoureteric reflux is often associated with kidney damage, mostly referred to as reflux nephropathy. It has been traditionally assumed that in primary vesicoureteric reflux kidney damage results from reflux of infected urine into the renal tissue but recent observations indicate that kidney damage sometimes occurs prenatally. In the overwhelming majority of patients with prenatally acquired renal damage the damage is linked with high-grade vesicoureteric reflux. In conclusion there are two categories of reflux disorder: a reflux associated with an acquired renal scarring secondary to infections and a prenatal high-grade vesicoureteric reflux linked with a congenital nephropathy.
Keywords: Reflux nephropathy, Urinary tract infection, Vesicoureteric reflux, Bladder dysfunction
Current Pediatric Reviews
Title: Primary Vesicoureteric Reflux and Reflux Nephropathy - New Insights
Volume: 2 Issue: 2
Author(s): Laura Santoro, Alessandra Ferrarini, Laura Crosazzo and Mario G. Bianchetti
Affiliation:
Keywords: Reflux nephropathy, Urinary tract infection, Vesicoureteric reflux, Bladder dysfunction
Abstract: Primary vesicoureteric reflux was felt to result from a congenitally short mucosal tunnel length with oblique intravescical insertion but more recent data suggest that primary vesicoureteric reflux is often associated with functional urodynamic abnormalities. There is now sound evidence that primary vesicoureteric reflux has a familial basis; most findings suggest a dominant inheritance with incomplete penetrance. Primary vesicoureteric reflux is often associated with kidney damage, mostly referred to as reflux nephropathy. It has been traditionally assumed that in primary vesicoureteric reflux kidney damage results from reflux of infected urine into the renal tissue but recent observations indicate that kidney damage sometimes occurs prenatally. In the overwhelming majority of patients with prenatally acquired renal damage the damage is linked with high-grade vesicoureteric reflux. In conclusion there are two categories of reflux disorder: a reflux associated with an acquired renal scarring secondary to infections and a prenatal high-grade vesicoureteric reflux linked with a congenital nephropathy.
Export Options
About this article
Cite this article as:
Santoro Laura, Ferrarini Alessandra, Crosazzo Laura and Bianchetti G. Mario, Primary Vesicoureteric Reflux and Reflux Nephropathy - New Insights, Current Pediatric Reviews 2006; 2 (2) . https://dx.doi.org/10.2174/157339606776894676
DOI https://dx.doi.org/10.2174/157339606776894676 |
Print ISSN 1573-3963 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6336 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The Effect of PDE5 Inhibitors on the Male Reproductive Tract
Current Pharmaceutical Design Angiotensin-I Converting Enzyme Inhibitors as Potential Anti-Angiogenic Agents for Cancer Therapy
Current Cancer Drug Targets Heterocyclic Chalcone Analogues as Potential Anticancer Agents
Anti-Cancer Agents in Medicinal Chemistry Serum Creatinine vs. Albuminuria as Biomarkers for the Estimation of Cardiovascular Risk
Current Vascular Pharmacology GSK3β 5'-flanking DNA Methylation and Expression in Alzheimer’s Disease Patients
Current Alzheimer Research Amphetamine-Type Medicines: A Review of Pharmacokinetics, Pharmacodynamics, and Toxicological Aspects.
Current Clinical Pharmacology Alzheimer’s Disease and Retinal Degeneration: A Glimpse at Essential Trace Metals in Ocular Fluids and Tissues
Current Alzheimer Research Hypertensive Versus HIV-infected Patients: Who Has the Greatest Target Organ Damage? Comparison of Carotid Plaque Prevalence, Intima Media Thickness and Renal Resistive Index in the Two Groups of Patients
Current Hypertension Reviews Angiotensin II Receptor Blocker: Possibility of Antitumor Agent for Prostate Cancer
Mini-Reviews in Medicinal Chemistry Dimethyl Sulfoxide as an Excitatory Modulator and its Possible Role in Cancer Pain Management
Inflammation & Allergy - Drug Targets (Discontinued) Pharmacokinetic and Pharmacodynamic Studies of Nifedipine Loaded Microspheres for the Treatment of Hypertension
Current Drug Delivery Mechanisms Underlying the Cardiovascular Effects of COX-Inhibition: Benefits and Risks
Current Pharmaceutical Design Atherogenic Versus Non-atherogenic Lipoprotein Profiles in Healthy Individuals. Is There a Need to Change Our Approach to Diagnosing Dyslipidemia?
Current Medicinal Chemistry Endothelial Dysfunction and Angiogenesis in Autosomal Dominant Polycystic Kidney Disease
Current Hypertension Reviews Comparison of Pharmacodynamics and Celiac Effects of Olmesartan Medoxomil Formulations by using Olmesartan-induced Celiac-rat-model
Current Drug Delivery Some Developments Regarding Functional Food Products (Functional Foods)
Current Nutrition & Food Science Obstructive Sleep Apnea Syndrome: Implications in Cardiovascular Disease
Current Respiratory Medicine Reviews Impact of Oral 1,25-Dihydroxy Vitamin D (Calcitriol) Replacement Therapy on Coronary Artery Risk Factors in Type 2 Diabetic Patients
Endocrine, Metabolic & Immune Disorders - Drug Targets “Cardiovascular” Drugs in Rheumatoid Arthritis: Killing Two Birds with One Stone?
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Impact of Traditional Therapies and Biologics on Cardiovascular Diseases in Rheumatoid Arthritis
Current Vascular Pharmacology